The PSMA-11-derived hybrid molecule PSMA-914 specifically identifies prostate cancer by preoperative PET/CT and intraoperative fluorescence imaging.
作者信息
Eder Ann-Christin, Omrane Mohamed A, Stadlbauer Sven, Roscher Mareike, Khoder Wael Y, Gratzke Christian, Kopka Klaus, Eder Matthias, Meyer Philipp T, Jilg Cordula A, Ruf Juri
机构信息
Department of Nuclear Medicine, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Division of Radiopharmaceutical Development, German Cancer Consortium (DKTK), partner site Freiburg, Freiburg, Germany and German Cancer Research Center, Heidelberg, Germany.
出版信息
Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):2057-2058. doi: 10.1007/s00259-020-05184-0. Epub 2021 Jan 23.
Abstract
摘要
相似文献
1
The PSMA-11-derived hybrid molecule PSMA-914 specifically identifies prostate cancer by preoperative PET/CT and intraoperative fluorescence imaging.
Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):2057-2058. doi: 10.1007/s00259-020-05184-0. Epub 2021 Jan 23.
2
Ga-Labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography for Prostate Cancer: A Systematic Review and Meta-analysis.
Eur Urol Focus. 2018 Sep;4(5):686-693. doi: 10.1016/j.euf.2016.11.002. Epub 2016 Nov 15.
3
Is there a utility of adding skeletal imaging to 68-Ga-prostate-specific membrane antigen-PET/computed tomography in initial staging of patients with high-risk prostate cancer?
Nucl Med Commun. 2020 Nov;41(11):1183-1188. doi: 10.1097/MNM.0000000000001268.
4
Ga-PSMA-11 PET/CT in recurrent prostate cancer: efficacy in different clinical stages of PSA failure after radical therapy.
Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):31-39. doi: 10.1007/s00259-018-4189-7. Epub 2018 Oct 22.
5
Gallium-68-prostate-specific membrane antigen ( Ga-PSMA) positron emission tomography (PET)/computed tomography (CT) predicts complete biochemical response from radical prostatectomy and lymph node dissection in intermediate- and high-risk prostate cancer.
BJU Int. 2019 Jul;124(1):62-68. doi: 10.1111/bju.14506. Epub 2019 Apr 7.
6
Comparison of preoperative locoregional Ga-68 PSMA-11 PET-CT and mp-MRI results with postoperative histopathology of prostate cancer.
Prostate. 2019 Jun;79(9):1007-1017. doi: 10.1002/pros.23812. Epub 2019 Apr 23.
7
Detection Efficacy of Hybrid Ga-PSMA Ligand PET/CT in Prostate Cancer Patients with Biochemical Recurrence After Primary Radiation Therapy Defined by Phoenix Criteria.
J Nucl Med. 2017 Jul;58(7):1081-1087. doi: 10.2967/jnumed.116.184457. Epub 2017 Feb 16.
8
In primary lymph nodal staging of patients with high-risk and intermediate-risk prostate cancer, how critical is the role of Gallium-68 prostate-specific membrane antigen positron emission tomography-computed tomography?
Nucl Med Commun. 2020 Feb;41(2):139-146. doi: 10.1097/MNM.0000000000001110.
9
Ga-PSMA-11 PET/CT-derived metabolic parameters for determination of whole-body tumor burden and treatment response in prostate cancer.
Eur J Nucl Med Mol Imaging. 2018 Oct;45(11):1862-1872. doi: 10.1007/s00259-018-4042-z. Epub 2018 May 3.
10
Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning.
J Nucl Med. 2018 Feb;59(2):230-237. doi: 10.2967/jnumed.117.201749. Epub 2017 Nov 9.
引用本文的文献
1
Intraoperative Confocal Laser Endomicroscopy Detects Prostate Cancer at the Single-Cell Level with High Specificity and in Real Time: A Preclinical Proof of Concept.
Pharmaceuticals (Basel). 2025 Jun 4;18(6):841. doi: 10.3390/ph18060841.
2
Advancements in molecular imaging probes for precision diagnosis and treatment of prostate cancer.
J Zhejiang Univ Sci B. 2025 Jan 15;26(2):124-144. doi: 10.1631/jzus.B2300614.
3
Dual-Labeled Small Peptides in Cancer Imaging and Fluorescence-Guided Surgery: Progress and Future Perspectives.
Pharmaceuticals (Basel). 2025 Jan 22;18(2):143. doi: 10.3390/ph18020143.
4
Lessons learned in application driven imaging agent design for image-guided surgery.
Eur J Nucl Med Mol Imaging. 2024 Aug;51(10):3040-3054. doi: 10.1007/s00259-024-06791-x. Epub 2024 Jun 20.
5
Prostate-specific membrane antigen-targeted surgery in prostate cancer: Accurate identification, real-time diagnosis, and precise resection.
Theranostics. 2024 Apr 22;14(7):2736-2756. doi: 10.7150/thno.95039. eCollection 2024.
6
Delphi consensus project on prostate-specific membrane antigen (PSMA)-targeted surgery-outcomes from an international multidisciplinary panel.
Eur J Nucl Med Mol Imaging. 2024 Aug;51(10):2893-2902. doi: 10.1007/s00259-023-06524-6. Epub 2023 Nov 28.
7
State of the Art in Prostate-specific Membrane Antigen-targeted Surgery-A Systematic Review.
Eur Urol Open Sci. 2023 Jun 16;54:43-55. doi: 10.1016/j.euros.2023.05.014. eCollection 2023 Aug.
8
Efforts toward PET-Activatable Red-Shifted Silicon Rhodamines and Silicon Pyronine Dyes.
Pharmaceuticals (Basel). 2023 Mar 7;16(3):401. doi: 10.3390/ph16030401.
9
The current status and future prospects for molecular imaging-guided precision surgery.
Cancer Imaging. 2022 Sep 6;22(1):48. doi: 10.1186/s40644-022-00482-2.
10
Dual-Labelling Strategies for Nuclear and Fluorescence Molecular Imaging: Current Status and Future Perspectives.
Pharmaceuticals (Basel). 2022 Mar 31;15(4):432. doi: 10.3390/ph15040432.
本文引用的文献
1
Synthesis and Preclinical Characterization of the PSMA-Targeted Hybrid Tracer PSMA-I&F for Nuclear and Fluorescence Imaging of Prostate Cancer.
J Nucl Med. 2019 Jan;60(1):71-78. doi: 10.2967/jnumed.118.212720. Epub 2018 Sep 20.
2
Robot-assisted laparoscopic surgery using DROP-IN radioguidance: first-in-human translation.
Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):49-53. doi: 10.1007/s00259-018-4095-z. Epub 2018 Jul 27.
3
PSMA-11-Derived Dual-Labeled PSMA Inhibitors for Preoperative PET Imaging and Precise Fluorescence-Guided Surgery of Prostate Cancer.
J Nucl Med. 2018 Apr;59(4):639-645. doi: 10.2967/jnumed.117.201293. Epub 2017 Nov 30.
4
The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer.
Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):197-209. doi: 10.1007/s00259-014-2949-6. Epub 2014 Nov 20.
5
68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging.
Bioconjug Chem. 2012 Apr 18;23(4):688-97. doi: 10.1021/bc200279b. Epub 2012 Mar 13.
6
Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients.
J Urol. 2007 Mar;177(3):916-20. doi: 10.1016/j.juro.2006.10.074.
Zotero 插件